Aquilo Capital Management, LLC Portfolio Holdings
Aquilo Capital Management, LLC
- $128 Million
- Q3 2024
Aquilo Capital Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $128 Million distributed in 14 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Arrowhead Pharmaceuticals, Inc. with a value of $15.4M, Blueprint Medicines Corp with a value of $11.5M, Kymera Therapeutics, Inc. with a value of $9.88M, Regenxbio Inc. with a value of $9.76M, and Arvinas, Inc. with a value of $9.58M.
Examining the 13F form we can see an increase of $28.5M in the current position value, from $100M to 128M.
Aquilo Capital Management, LLC is based out at San Francisco, CA
Below you can find more details about Aquilo Capital Management, LLC portfolio as well as his latest detailed transactions.